THE ANTIBACTERIAL COMPOUND COLLISMICIN A DERIVED FROM MARINE  Streptomyces  sp Q-629K

Tutik Murniasih; Kyoko Adachi

doi:10.22146/ijc.21600

THE ANTIBACTERIAL COMPOUND COLLISMICIN A DERIVED FROM MARINE Streptomyces sp Q-629K

https://doi.org/10.22146/ijc.21600

Tutik Murniasih^(1*), Kyoko Adachi⁽²⁾

(1) Research Center for Oceanography Indonesian Institute of Sciences Jl. Pasir putih No. 1 Ancol Timur Jakarta 14430
(2) Marine Biotechnology Institute Co. Ltd., Kamaishi Lab.,3-75-1 Heita, Iwate 026-0001, Kamaishi City
(*) Corresponding Author

Abstract

In our course of screening for secondary metabolite derived from marine bacterial, we isolate the antimicrobial compound collysmicin A from the ethyl acetate extract of Streptomyces sp Q-629K. Separation of this compound was carried out by silica gel open column chromatography. Purification of an active compound was done using HPLC C18 with acetonitril-water system. Determination of chemical structure was done by ¹H, ¹³C NMR and LC-MS analysis. Collysmicin A was contained in fraction 3, fraction 7.2 and fraction 8.7. The antimicrobial assayed from purified compound Fr.8.7 gave diameter inhibition approximately 13 mm against S. aureus and 12 mm against B. subtilis.

Keywords

antimicrobial; collismycin A; marine Streptomyces sp

Full Text:

Full Text Pdf

References

[1] Berdy, J., 1982, Search and Discovery Methods for Novel Antimicrobials in: Bioactive Metabolites from Microorganisms (M.E. Bushell and U. Grafe, eds), Elsevier, Amsterdam, pp. 3-25.

[2] Beetina, V., 1983, The Chemistry and Biology of Antibiotics, Elsevier, Amsterdam.

[3] Fusetani, N., 2000, Drugs from The Sea. Karger, Basel Switzerland, pp.1-5

[4] Burkholder, P.R., Pfister, R.M., and Leitz, F.P., 1966, Appl. Microbiol. 15:85-89.

[5] Kitahara, T., Naganawa, H., Okazaki, T., Okami, Y., and Umezawa, H., 1975, J. Antibiot. 28:280.

[6] Okazaki, T., Kitahara, T., and Okami, Y., 1975, J. Antibiot. 28:176-184.

[7] Hotta, K., Yoshida, T., Hamada, M., and Okami, Y., 1980, J. Antibiot. 33:1515.

[8] Okami, Y., Okazaki,T., Kitahara, T., and Umezawa, H., 1976, J. Antibiot. 29:1019-1025.

[9] Sato, K., Okazaki, T., Maeda, K., and Okami, Y., 1978, J. Antibiot. 31:632

[10] Shindo, K., Yamagishi, Y., Okada, Y., Kawai, H., 1994, J. Antibiot. vol.47 no.9. 1072-1074.

[11] Tsuge, N., Furihata, K., Shin-Ya, K., Seto, H., 1999, J. Antibiot. vol. 52, No.5 pp105-107.

[12] Gomi, S., Ito, S., Azito, K., Kariya, Y., and Koyama, M. (Meiji Seika Kaisya, Ltd.), (1993) A New Microbial and Antitumor Agent SF2738. Jpn. Kokai 78322 (’93).

DOI: https://doi.org/10.22146/ijc.21600